Yumeng Wang

A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.

Leng Han, Yiling Lu, Zhicheng Zhou, 2018, Cancer cell.

Enhancing Structure Prediction and Design of Soluble and Membrane Proteins with Explicit Solvent-Protein Interactions.

Jason K Lai, Patrick Barth, P. Barth, 2017, Structure.

Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.

Jun Li, Hu Chen, Yuan Yuan, 2016, Cancer cell.

Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.

Hu Chen, Hai Hu, Jun Li, 2018, Cell reports.

TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data*

Yiling Lu, Rehan Akbani, Han Liang, 2019, Molecular & Cellular Proteomics.

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

Leng Han, Jun Li, Hu Chen, 2018, Cell reports.

Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.

Leng Han, Jun Li, Yiling Lu, 2017, Genome research.

Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

Zhongming Zhao, Feixiong Cheng, Jun Li, 2018, Cell reports.

When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference

Han Liang, Han Liang, Yumeng Wang, 2018, BioEssays : news and reviews in molecular, cellular and developmental biology.